European course on HPV associated pathology: Guidelines for primary care physicians for the diagnosis and management of anogenital warts

Sexually Transmitted Infections

Volumn 76, Issue 3, 2000, Pages 162-168

  von Krogh, G ^a   Lacey, Charles J N ^b   Gross, G ^c   Barrasso, R ^d   Schneider, A ^e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^d Bichat and Salpetriere University Hospitals   (France)

^e FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Anogenital warts; Condylomata acuminata; Guidelines; Human papillomavirus

Indexed keywords

ACETIC ACID; IMIQUIMOD; PODOPHYLLOTOXIN; TRICHLOROACETIC ACID;

ARTICLE; BOWEN DISEASE; BOWENOID PAPULOSIS; CLINICAL TRIAL; COLPOSCOPY; CONDYLOMA ACUMINATUM; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; ELECTROSURGERY; ERYTHEMA; EUROPE; FIBROMA; GIANT CONDYLOMA ACUMINATUM; HISTOPATHOLOGY; HUMAN; MOLLUSCUM CONTAGIOSUM; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECTOSCOPY; SEBORRHEIC KERATOSIS; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADJUVANTS, IMMUNOLOGIC; ALGORITHMS; AMINOQUINOLINES; CAUSTICS; CONDYLOMATA ACUMINATA; DIAGNOSIS, DIFFERENTIAL; FAMILY PRACTICE; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; MALE; PAPILLOMAVIRIDAE; REFERRAL AND CONSULTATION; TRICHLOROACETIC ACID;

EID: 0033918893     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.76.3.162     Document Type: Article

References (55)

1. 1 Gross G, Ikenberg H, Gissmann L, et al. Papillomavirus infection of the anogenital region: correlation between histology, clinical picture and virus type. J Invest Dermatol 1985;85:147-52.
2. 2 Syrjänen K, Syrjänen S. Epidemiology of human papillomavirus infections and genital neoplasia. ScanJ J Infect Dis Suppl 1990;60:7-17.
3. 3 Syrjänen KJ. Long term consequences of genital HPV infections in women. Ann Med 1992;24:233-45.
4. 4 Oriel JD. Natural history of genital warts. Br J Vener Dis 1971;47:1-13.
5. 5 Cook LS, Koutsky LA, Holmes KK. Clinical presentation of genital warts among circumcised and uncircumcised heterosexual men attending an urban STD clinic. Genitourin Med 1993;69:262-4.
6. 6 Chuang T-Y, Perry HO, Kurland LT, et al. Condyloma acuminatum in Rochester, Minn, 1950-1978. I. Epidemiology and clinical features. Arch Dermatol 1984;120:469-75.
7. 7 Sonnex C, Schofield JH, Kocjan G, et al. Anal human papillomavirus infection in heterosexuals with genital warts: prevalence and relation with sexual behaviour. BMJ 1991; 303:1243.
8. 8 Barrasso R, Gross G. External genitalia: diagnosis. In: Gross, Barrasso, eds. Human papillomavirus infection. A clinical atlas. Berlin-Wiesbaden: Ullstein-Mosby, 1997: 291-361.
9. 9 Von Krogh G, Gross G, Barrasso R. Warts and HPV-related squamous cell tumours of the genitoanal area in adults. In: Gross, Von Krogh, eds. Human papillomavirus infections in dermato-venereology. Boca Raton, FL: CRC Press, 1997: 259-304.
10. 10 Gross G, Hagedorn M, Ikenberg H, et al. Bowenoid papulosis. Presence of human papillomavirus (HPV) structural antigens and of HPV 16-related DNA sequences. Arch Dermatol 1985;121:858-63.
11. 11 Demeter LM, Stoler MH, Bonnez W, et al. Penile intraepithelial neoplasia: clinical presentation and an analysis of the physical state of human papillomavirus DNA. J Infect Dis 1993;168:38-46.
12. 12 Maw RD, Reitano M, Roy M. An international survey of patients with genital warts; perceptions regarding treatment and impact on lifestyle. Int J STD AIDS 1998;9:571-8.
13. 13 Taylor CA, Keller ML, Egan JJ. Advice from affected persons about living with human papillomavirus infection. Image J Nurs Schol 1997;29:27-32.
14. 14 Van Beurden M, ten Kate FJ, Smits HL, et al. Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus. Cancer 1995;75: 2879-84.
15. 15 Hording U, Daugaard S, Junge J, et al. Human papillomaviruses and multifocal genital neoplasia. Int J Gynecol Pathol 1996;15:230-4.
16. 16 Wikström A, Hedbland MA, Johansson B, et al. The acetic acid test in evaluation of subclinical genital papiliomavirus infection: a comparative study on penoscopy, histopathology, virology and scanning electron microscopy findings. Genitourin Med 1992;68:90-9.
17. 17 Centers for Disease Control and Prevention. Guidelines for treatment of sexually transmitted diseases. MMWR 1998; 47(RR-1):1-111.
18. 18 Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National guideline for the management of anogenital warts. Sex Transm Inf 1999;75(Suppl 1):S71-5.
19. 19 US Department of Health and Human Services, Agency for Health Care Policy and Research. Acute pain management: operative or medical procedures and trauma. Clinical Practice Guidelines No 1. Rockville, MD: AHCPR. Publication No 92-0023, 1993:107.
20. 20 Von Krogh G. Podophyllotoxin for condylomata acuminata eradication. Clinical and experimental comparative studies on Podophyllum lignans, colchicine and 5-fluorouracil. Thesis. Acta Dermatovenerol Suppl 1991; 98:1-48.
21. 21 Von Krogh G. Penile condylomata acuminata: an experimental model for evaluation of topical treatment with 0.5-1.0% ethanolic preparations of podophyllotoxin for three days. Sex Transm Dis 1981;8:179-84.
22. 22 Von Krogh G, Szpak E, Andersson M, et al. Self-treatment using 0.25%-0.5% podophyllotoxin ethanol solutions against penile condylomata acuminata - a placebo-controlled comparative study. Genitourin Med 1994;70: 105-9.
23. 23 Beutner KR, Conant MA, Friedman-Kien A. Patient-applied podofilox for treatment of genital warts. Lancet 1989;i:831-4.
24. 24 Greenberg MD, Rutledge LH, Reid, et al. A double blind randomized trial of 0.5% podofilox and placebo in the treatment of genital warts in women. Obstet Gynecol 1991; 77:735-9.
25. 25 Kirby P, Dunne A, King DH, et al. Double-blind randomized clinical trial of self-administered podofilox solution vehicle in the treatment of genital warts. Am J Med 1990;88:465-70.
26. 26 Claesson U, Lassus A, Happonen H, et al. Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution. Int J STD AIDS 1996;7:429-34.
27. 27 Strand A, Brinkeborn R-M, Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourin Med 1995;7: 387-90.
28. 28 Sand Peterson C, Agner T, Ottevanger V, et al. A single-blind study of podophyllotoxin cream 0.5% and podophyllotoxin solution 0.5% in male patients with genital warts. Genitourin Med 1995;71:391-2.
29. 20 Tyring SK, Arany I, Stanley MA, et al. A randomised, controlled, molecular study of condylomata acuminata clearance drug treatment with imiquimod. J Infect Dis 1998;178:551-5.
30. 30 Miller RL, Gerster JF, Owens MA, et al. Imiquimod applied topically: a novel immune response modifier and new class of drug. Int J Immunopharmacol 1999;21:1-14.
31. 31 Edwards L, Ferenezy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998;134:25-30.
32. 32 Gollnick H, Barasso R, Benninghoff B, et al. Safety and efficacy of imiquimod 5% cream in uncircumcised males with foreskin-associated genital warts. Poster No P711 at the 8th Congress of the European Academy of Dermatology and Venereology (EADV), 29 September 3 October 1999.
33. 33 Drake LA, Ceilley RI, Cornelison RL, et al. Guidelines of care for warts: human papillomavirus. J Am Acad Dermatol 1995;32:98-103.
34. 34 Von Krogh G, Wikström A. Efficacy of chemical and or surgical therapy against condylomata acuminata: a retrospective evaluation. Int J STD AIDS 1991;2:333-8.
35. 35 Simmonds PD, Langlet F, Thin RN. Cryotherapy versus electrocautery in the treatment of genital warts. Br J Vener Dis 1981;57:273-4.
36. 36 Stone KM, Becker TM, Hagdu A, et al. Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy and electrodessication. Genitourin Med 1990;66:16-19.
37. 37 Godley MJ, Bradbeer CS, Gellan M, et al. Cryotherapy compared with trichloracetic acid in treating genital warts. Genitourin Med 1987;63:390-2.
38. 38 Abdullah AN, Walzman M, Wade A. Treatment of external genital warts comparing cryotherapy (liquid nitrogen) and trichloracetic acid. Sex Transm Dis 1993;20;344-5.
39. 30 Wein AJ, Benson GS. Treatment of urethral condyloma acuminatum with 5-fluorouracil cream. Urology 1977;9: 413-5.
40. 10 Gross G, Roussaki A, Baur S, et al. Systemically administered Interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation influence of the cyclic low-close therapy regime. Genitourin Med 1996;76:71.
41. 41 Gross G, Rogozinski T, Schöfer H, et al. Recombinant interferon beta gel as an adjuvant in the treatment of recurrent genital warts: results of a placebo-controlled double blind study in 120 patients. Dermatology 1998:196:330-4.
42. 42 Jensen SL. Comparison of podophyllin application with simple excision in clearance and recurrences of perianal condylomata acuminata. Lancet 1986;ii:1446-8.
43. 43 Sand Petersen C, Weismann K. Quercetin and kaempherol; an argument against the use of podophyllin? Genitourin Med 1995;71:92-3.
44. 44 Von Krogh G. Podophyllotoxin in serum: absorption subsequent to three-day repeated application of a 0.5% ethanol preparation on condylomata acuminata. Sex Transm Dis 1982;9:26-30.
45. 45 Leslie KO, Shitamoto B. The bone marrow in systemic podophyllin toxicity. Am J Clin Pathol 1982;77:478-82.
46. 46 Miller RA. Podophyllin. Int J Dermatol 1985;24:491-8.
47. 47 Tomczak RL, Hake DH. Near fatal systemic toxicity from local injection of podophyllin for pedal verrucae treatment. J Foot Surg 1992;3:36-42.
48. 48 Fisher AA. Severe systemic and local reactions to topical podophyllum resin. Cutis 1987; 28:233-66.
49. 40 Feldman JG, Chirgwin K, Dehovitz JA, et al. The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol 1997;89:346-50.
50. 50 Kemp EA, Hakenworth AM, Laurent SL, et al. Human papillomavirus prevalence in pregnancy. Obstet Gynecol 1992;79:619-56.
51. 51 Kashima HK, Shah K. Recurrent respiratory papillomatosis: clinical overview and management principles. Obstet Gynecol Clinics North Am 1987;14:581-8.
52. 52 Euvrard S, Kanitakis J, Chardonnet Y, et al. External anogenital lesions in organ transplant recipients. A clinicopathologic and virologic assessment. Arch Dermatol 1997; 133:175-8.
53. 53 Alloub MI, Barr BB, McLaren KM, et al. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts. BMJ 1989;298:153-6.
54. 54 Lacey CJN. Genital warts in children. Papillomavirus Report 1996;7:83-7.
55. 55 Ingram DL, Everett VD, Lyna PR, et al. Epidemiology of adult sexually transmitted disease agents in children being evaluated for sexual abuse. Pediatr Infect Dis J 1992;11: 945-50.